• Raised A$1.95 million through a placement to institutional and sophisticated investors
• Funds to be used for international growth, inventory build, and new product registrations
• Participants to receive free attaching options, subject to shareholder approval

ECS Botanics Holdings Ltd (ASX: ECS), a leading medicinal cannabis company, has received binding commitments to raise approximately A$1.95 million (before costs) through the issue of approximately 300 million new fully paid ordinary shares at A$0.0065 per share. The placement was well supported by new and existing institutional and sophisticated investors, reflecting growing market confidence in ECS's strategy and momentum across its B2C and international business units. Proceeds from the placement, together with existing cash and debt facilities, will be directed towards funding new product registrations, including innovative delivery formats for the ECS product range; strategic inventory purchases to support growing domestic and export sales volumes; and expansion of ECS's international distribution footprint, particularly in Europe. As part of the placement, participants will also receive one free attaching option per share, exercisable at A$0.011 and expiring 2.5 years from the date of issue, subject to shareholder approval. Additionally, the company intends to reward shareholder loyalty by issuing Loyalty Options on the same terms as the Placement Options, on a 1-for-6 basis to eligible shareholders on the record date.

ECS is positioned to accelerate growth across key markets as it continues to scale up its product portfolio and global distribution strategy.